Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector

Gene Therapy

Volumn 7, Issue 6, 2000, Pages 534-539

  Beall, C J ^a,b   Phipps, A J ^c   Mathes, L E ^c   Stromberg, P ^c   Johnson, P R ^a,b,c,d  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b Immunology and Medical Genetics   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Adeno associated virus; Cats; Chronic renal failure; Erythropoietin

Indexed keywords

ANTIBODY; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ADENOVIRUS; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CAT; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; EXPRESSION VECTOR; FEMALE; GENE TRANSFER; HEMATOCRIT; MORBIDITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNITED STATES;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; FELIDAE; FELIS CATUS;

EID: 0034019950     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301126     Document Type: Article

References (17)

1. Kessler PD et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082-14087.
2. Snyder RO et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 1997; 8: 1891-1900.
3. Zhou S, Murphy JE, Escobedo JA, Dwarki VJ. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Therapy 1998; 5: 665-670.
4. Ye X et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 1999; 283: 88-91.
5. Cowgill LD. Pathophysiology and management of anemia in chronic progressive renal failure. Semin Vet Med Surg 1992; 7: 175-182.
6. Henry PA. Human recombinant erythropoetin used to treat a cat with anemia caused by chronic renal failure. Can Vet J 1994; 35: 375.
7. Clark KR, Voulgaropoulou F, Johnson PR. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Therapy 1996; 3: 1124-1132.
8. Hendrickson EA. The SCID mouse: relevance as an animal model system for studying human disease. Am J Pathol 1993; 143: 1511-1522.
9. Ersler AJ. Erythropoietin. New Engl J Med 1991; 324: 1339-1344.
10. Lulich JP, Osborne CA, O'Brien TD, Plozin DJ. Feline renal failure: questions, answers, questions. Com Cont Ed Pract Vet 1992; 14: 127-153.
11. The information exchange. Dog and cat ownership, 1991-1998. J Am Vet Med 1999; 204: 1166-1167.
12. Bohl D, Salvetti A, Moullier P, Heard JM. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998; 92: 1512-1517.
13. Rendahl KG et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 1998; 16: 757-761.
14. Wen D et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 1993; 82: 1507-1516.
15. Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR. Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995; 6: 1329-1341.
16. Clark KR, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adeno-associated virus stocks are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031-1039.
17. Cook SM, Lothrop CD. Serum erythropoietin concentrations measured by radioimmunoassay in normal, polycythemic, and anemic dogs and cats. J Vet Intern Med 1994; 8: 18-25.